Aspenwood Capital Announces Placement of $5 Million for LifeVantage

Friday, March 5, 2010 General News
Email Print This Page Comment bookmark
Font : A-A+

SAN DIEGO, March 4 LifeVantage Corporation (OTC Bulletin Board: LFVN), the maker of science-based solutions to oxidative stress, announced the final closing for $5M placed by Aspenwood Capital.


LifeVantage Corporation (OTCBB: LFVN) announced today that Aspenwood Capital (, a Denver-based investment bank and a division of Buckman, Buckman & Reid, Inc., has completed a $5 million private placement for the Company to accredited investors. LifeVantage ( is a science-based, natural products company dedicated to helping people reach their health and wellness goals through science-based solutions. LifeVantage is the maker of ProtandimŪ - a dietary supplement clinically shown to induce the body's own antioxidant defenses.

Aspenwood Capital partner Steve Ossello said, "The Aspenwood partners have always been tremendous supporters of the company and its primary product - ProtandimŪ. The science behind Protandim is incredible and given the recent quality additions to the board and the significant growth LifeVantage is experiencing, we're very excited about its potential."

LifeVantage CEO and President David Brown said, "We are extremely pleased with Aspenwood's continued support. The quality of both the institutional and individual investors that they have brought to our company is truly remarkable. We're confirming that this raise provides the company with the capital it needs to get through profitability."

About Aspenwood Capital

Aspenwood Capital ( of Denver, Colo., a division of Buckman, Buckman and Reid (member FINRA / SIPC), specializes in providing investment banking services to small-cap public issuers and late-stage private companies.

About LifeVantage Corporation

LifeVantage Corporation is a publicly traded (OTCBB: LFVN), science-based, nutraceutical company dedicated to helping people reach their health and wellness goals. Founded in 2003 and based in San Diego, CA, LifeVantage develops products, including ProtandimŪ, that are intended to deliver significant health benefits to consumers. For more information, visit

Forward Looking Statements

This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe," "hopes," "intends," "estimates," "expects," "projects," "plans," "anticipates" and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, the potential failure or unintended negative consequences of the implementation of the Company's network marketing sales channel; the Company's ability to retain independent distributors or to attract new independent distributors on an ongoing basis; the potential for third party and governmental actions involving the Company's network marketing sales channel; the potential for product liability claims against the Company; the risk that government regulators and regulations could adversely affect the Company's business; future laws or regulations may hinder or prohibit the production or sale of the Company's existing product and any future products; unfavorable publicity could materially hurt the Company's business; and the Company's ability to protect its intellectual property rights and the value of its product. These and other risk factors are discussed in greater detail in the Company's Annual Report on Form 10-K and its Quarterly Report on Form 10-Q under the caption "Risk Factors", and in other documents filed by the Company from time to time with the Securities and Exchange Commission. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.

Investor Relations Contact: Ioana C. Hone (858) 312-8000 Ext. 4

SOURCE LifeVantage Corporation

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store